A capital-efficient, high-margin biotechnology with defensible IP, a clear five-year scale-up path, and direct exposure to the global $4B+ chitosan market.
Recycled marine waste volumes scale through expanded sourcing partnerships and process optimisation, lifting facility utilisation toward full capacity by 2030.
| Year | Waste Recycled (KG) | Projected Output Value | Facility Capacity |
|---|---|---|---|
| 2026 | 12 000 | R1.68m | 30% |
| 2027 | 24 000 | R3.36m | 60% |
| 2028 | 36 000 | R6.34m | 75% |
| 2029 | 54 000 | R9.50m | 90% |
| 2030 | 81 000 | R14.26m | 100% |
All figures in South African Rand (ZAR). Projections based on conservative waste-intake scale-up and confirmed offtake interest.
A fully circular value chain — sourcing crustacean shell waste, processing it into industrial-grade chitosan, and distributing high-margin formulations into agriculture, pharma and water treatment.
Partnered with seafood processors to convert shell waste into a low-cost feedstock.
Proprietary extraction yielding food-, agri- and (from 2028) nano-grade chitosan.
Three flagship farm-ready SKUs plus bulk supply to pharma and water-treatment partners.
Local sales through agri channels with a clear path to export markets in EU and Asia.
The global chitosan market is projected to surpass $4 billion by 2030, growing at a 14.5% CAGR. Demand is driven by the shift to bio-based agriculture, sustainable pharma excipients and tighter water-treatment regulation.
Detailed pitch deck, unit economics and capex requirements available on request under NDA.
Contact Investor Relations →